- Home
- ROG vs ETNB Comparison
ROG vs ETNB Comparison
Compare ROG & ETNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROG
- ETNB
- Stock Information
- Founded
- ROG 1832
- ETNB 2018
- Country
- ROG United States
- ETNB United States
- Employees
- ROG N/A
- ETNB N/A
- Industry
- ROG Industrial Machinery/Components
- ETNB Biotechnology: Pharmaceutical Preparations
- Sector
- ROG Technology
- ETNB Health Care
- Exchange
- ROG Nasdaq
- ETNB Nasdaq
- Market Cap
- ROG 1.3B
- ETNB 1.5B
- IPO Year
- ROG N/A
- ETNB 2019
- Fundamental
- Price
- ROG $66.95
- ETNB $10.08
- Analyst Decision
- ROG Strong Buy
- ETNB Strong Buy
- Analyst Count
- ROG 2
- ETNB 8
- Target Price
- ROG $85.00
- ETNB $26.43
- AVG Volume (30 Days)
- ROG 162.1K
- ETNB 2.2M
- Earning Date
- ROG 07-24-2025
- ETNB 08-04-2025
- Dividend Yield
- ROG N/A
- ETNB N/A
- EPS Growth
- ROG N/A
- ETNB N/A
- EPS
- ROG 0.90
- ETNB N/A
- Revenue
- ROG $807,200,000.00
- ETNB N/A
- Revenue This Year
- ROG N/A
- ETNB N/A
- Revenue Next Year
- ROG $8.37
- ETNB N/A
- P/E Ratio
- ROG $74.75
- ETNB N/A
- Revenue Growth
- ROG N/A
- ETNB N/A
- 52 Week Low
- ROG $51.43
- ETNB $4.16
- 52 Week High
- ROG $134.07
- ETNB $11.84
- Technical
- Relative Strength Index (RSI)
- ROG 48.10
- ETNB 57.88
- Support Level
- ROG $67.86
- ETNB $9.66
- Resistance Level
- ROG $71.56
- ETNB $10.58
- Average True Range (ATR)
- ROG 1.74
- ETNB 0.55
- MACD
- ROG -0.24
- ETNB -0.09
- Stochastic Oscillator
- ROG 28.75
- ETNB 58.39
About ROG Rogers Corporation
Rogers Corporation designs develop and manufacture engineered materials and components for sale to original equipment manufacturers and component suppliers. The firm operates in three business segments: Advanced Electronics Solutions, which manufactures circuit materials for applications in communications infrastructure, automotive, and consumer electronics markets; elastomeric material solutions, which provide cushioning, sealing, and impact protection in automotive, transportation, and construction applications; and Other, which consists of elastomer components for applications in the general industrial market, as well as elastomer floats for level sensing in fuel tanks, motors, and storage tanks applications in the general industrial and automotive markets.
About ETNB 89bio Inc.
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).